Search research articles
Contact Us
Filters
Showing results (1-10 of 202) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2024
Reply to N. Okano et al
Anant Ramaswamy, Vikas Ostwal
Nuclear Medicine Communications
|
April 23, 2016
Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: is redifferentiation akin phenomenon a reality in neuroendocrine tumors?
Sandip Basu, Vikas Ostwal
Translational Gastroenterology and Hepatology
|
December 22, 2017
What drives the wheel towards long-term outcome in advanced GIST, its size, genotype or may be a pill or two of imatinib?
Vikas Ostwal, Anant Ramaswamy
International Journal of Rheumatic Diseases
|
April 9, 2010
Type B insulin resistance in a systemic lupus erythematosus patient
Vikas Ostwal, Jyotsna Oak
European Journal of Nuclear Medicine and Molecular Imaging
|
August 21, 2016
The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios
Sandip Basu, Vikas Ostwal
Journal of Gastrointestinal Cancer
|
January 21, 2020
Real-World Long-Term Outcomes with Perioperative EOX in D2 Gastrectomy: a Meaningful Look While We Switch to FLOT-4
Anant Ramaswamy, Prabhat Bhargava, Vikas Ostwal
Journal of Gastrointestinal Oncology
|
June 11, 2016
Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experience
Arvind Sahu, Anant Ramaswamy, Vikas Ostwal
Chinese Clinical Oncology
|
April 5, 2019
A step ahead on CTHRC1, and not just reinventing the wheel!
Siddharth Turkar, Anant Ramaswamy, Vikas Ostwal
The National Medical Journal of India
|
June 12, 2012
Metastatic pancreatic cancer: another option?
Shailesh V Shrikhande, Sudeep Gupta, Vikas Ostwal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 13, 2014
Supportive measures and finer practice points in 177Lu-DOTATATE PRRT for NET: aiming for optimal disease management
Sandip Basu, Vikas Ostwal, Rohit Ranade, et al.
Page
of 21
Search research articles
Search
Showing results (1-10 of 202) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2024
Reply to N. Okano et al
Anant Ramaswamy, Vikas Ostwal
Nuclear Medicine Communications
|
April 23, 2016
Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: is redifferentiation akin phenomenon a reality in neuroendocrine tumors?
Sandip Basu, Vikas Ostwal
Translational Gastroenterology and Hepatology
|
December 22, 2017
What drives the wheel towards long-term outcome in advanced GIST, its size, genotype or may be a pill or two of imatinib?
Vikas Ostwal, Anant Ramaswamy
International Journal of Rheumatic Diseases
|
April 9, 2010
Type B insulin resistance in a systemic lupus erythematosus patient
Vikas Ostwal, Jyotsna Oak
European Journal of Nuclear Medicine and Molecular Imaging
|
August 21, 2016
The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios
Sandip Basu, Vikas Ostwal
Journal of Gastrointestinal Cancer
|
January 21, 2020
Real-World Long-Term Outcomes with Perioperative EOX in D2 Gastrectomy: a Meaningful Look While We Switch to FLOT-4
Anant Ramaswamy, Prabhat Bhargava, Vikas Ostwal
Journal of Gastrointestinal Oncology
|
June 11, 2016
Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experience
Arvind Sahu, Anant Ramaswamy, Vikas Ostwal
Chinese Clinical Oncology
|
April 5, 2019
A step ahead on CTHRC1, and not just reinventing the wheel!
Siddharth Turkar, Anant Ramaswamy, Vikas Ostwal
The National Medical Journal of India
|
June 12, 2012
Metastatic pancreatic cancer: another option?
Shailesh V Shrikhande, Sudeep Gupta, Vikas Ostwal
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 13, 2014
Supportive measures and finer practice points in 177Lu-DOTATATE PRRT for NET: aiming for optimal disease management
Sandip Basu, Vikas Ostwal, Rohit Ranade, et al.
Page
of 21